Skip to main content
OpenTrials

Clinical trial condition

Stage III Adrenal Cortical Carcinoma AJCC v8

Explore clinical trials studying Stage III Adrenal Cortical Carcinoma AJCC v8. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Stage III Adrenal Cortical Carcinoma AJCC v8 trial results

Recruiting

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

NCT06900595

Conditions
Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +16 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Valley Children's Hospital Madera, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • Lurie Children's Hospital-Chicago Chicago, Illinois, United States
View all 77 locations
View Trial Details

Related conditions